Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease ; volume:29 ; number:8 ; day:7 ; month:8 ; year:2023 ; pages:1979-1988 ; date:8.2023
Nature medicine ; 29, Heft 8 (7.8.2023), 1979-1988, 8.2023
- Urheber
-
Johnson, Erik C. B.
Bian, Shijia
Haque, Rafi U.
Carter, E. Kathleen
Watson, Caroline M.
Gordon, Brian A.
Ping, Lingyan
Duong, Duc M.
Epstein, Michael P.
McDade, Eric
Barthélemy, Nicolas R.
Karch, Celeste M.
Xiong, Chengjie
Cruchaga, Carlos
Perrin, Richard J.
Wingo, Aliza P.
Wingo, Thomas S.
Chhatwal, Jasmeer P.
Day, Gregory S.
Noble, James M.
Berman, Sarah B.
Martins, Ralph
Graff-Radford, Neill R.
Schofield, Peter R.
Ikeuchi, Takeshi
Mori, Hiroshi
Levin, Johannes
Farlow, Martin
Lah, James J.
Haass, Christian
Jucker, Mathias
Morris, John C.
Benzinger, Tammie L. S.
Roberts, Blaine R.
Bateman, Randall J.
Fagan, Anne M.
Seyfried, Nicholas T.
Levey, Allan I.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-023-02476-4
- URN
-
urn:nbn:de:101:1-2024010810060934177217
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Johnson, Erik C. B.
- Bian, Shijia
- Haque, Rafi U.
- Carter, E. Kathleen
- Watson, Caroline M.
- Gordon, Brian A.
- Ping, Lingyan
- Duong, Duc M.
- Epstein, Michael P.
- McDade, Eric
- Barthélemy, Nicolas R.
- Karch, Celeste M.
- Xiong, Chengjie
- Cruchaga, Carlos
- Perrin, Richard J.
- Wingo, Aliza P.
- Wingo, Thomas S.
- Chhatwal, Jasmeer P.
- Day, Gregory S.
- Noble, James M.
- Berman, Sarah B.
- Martins, Ralph
- Graff-Radford, Neill R.
- Schofield, Peter R.
- Ikeuchi, Takeshi
- Mori, Hiroshi
- Levin, Johannes
- Farlow, Martin
- Lah, James J.
- Haass, Christian
- Jucker, Mathias
- Morris, John C.
- Benzinger, Tammie L. S.
- Roberts, Blaine R.
- Bateman, Randall J.
- Fagan, Anne M.
- Seyfried, Nicholas T.
- Levey, Allan I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
Discovery and validation of autosomal dominant Alzheimer’s disease mutations
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Metabolite profiling of Alzheimer's disease cerebrospinal fluid
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
Discovery and validation of autosomal dominant Alzheimer’s disease mutations
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Metabolite profiling of Alzheimer's disease cerebrospinal fluid
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
Discovery and validation of autosomal dominant Alzheimer’s disease mutations
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Metabolite profiling of Alzheimer's disease cerebrospinal fluid
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease